The project, led by Prof. Sylvain Lehmann, head of the Clinical Biochemistry and Proteomics Laboratory at the Montpellier University Hospital, focuses on the « Spike » protein. This protein plays a crucial role in the disease mechanism associated with the SARS-CoV-2 virus.
The press release also mentions other events and care offerings within the institution, including information on emergencies, rare diseases, personalized medicine, cancer, as well as training sessions at the IFMS and congresses at the Corum in Montpellier.
